drugset / Trial / NCT02997982

Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease

NCT02997982

Phase 2 Completed 33 enrolled Hugo Lovheim
NaSingle-groupOpen-labelTreatment

Summary

This study investigates the effects of Valaciclovir treatment to individuals with Alzheimer's disease or Mild Cognitive Impairment of Alzheimer's Disease Type. It is an open pilot trial where 36 participants will receive 4 weeks of Valaciclovir treatment. Participants will be investigated using different measures before and after the treatment period.

Timeline

Start
2016-12
Primary completion
2020-03-04
Completion
2020-03-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Valaciclovir Unknown 1000 mg Oral